- Home
- CUE vs VOR Comparison
CUE vs VOR Comparison
Compare CUE & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- VOR
- Stock Information
- Founded
- CUE 2014
- VOR 2015
- Country
- CUE United States
- VOR United States
- Employees
- CUE N/A
- VOR N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- CUE Health Care
- VOR Health Care
- Exchange
- CUE Nasdaq
- VOR Nasdaq
- Market Cap
- CUE 64.4M
- VOR 59.3M
- IPO Year
- CUE 2018
- VOR 2021
- Fundamental
- Price
- CUE $1.25
- VOR $0.86
- Analyst Decision
- CUE Strong Buy
- VOR Strong Buy
- Analyst Count
- CUE 5
- VOR 7
- Target Price
- CUE $5.00
- VOR $11.36
- AVG Volume (30 Days)
- CUE 971.4K
- VOR 614.4K
- Earning Date
- CUE 11-14-2024
- VOR 11-07-2024
- Dividend Yield
- CUE N/A
- VOR N/A
- EPS Growth
- CUE N/A
- VOR N/A
- EPS
- CUE N/A
- VOR N/A
- Revenue
- CUE $9,532,000.00
- VOR N/A
- Revenue This Year
- CUE $104.81
- VOR N/A
- Revenue Next Year
- CUE N/A
- VOR N/A
- P/E Ratio
- CUE N/A
- VOR N/A
- Revenue Growth
- CUE 149.53
- VOR N/A
- 52 Week Low
- CUE $0.45
- VOR $0.63
- 52 Week High
- CUE $3.25
- VOR $3.14
- Technical
- Relative Strength Index (RSI)
- CUE 43.10
- VOR 53.71
- Support Level
- CUE $1.32
- VOR $0.75
- Resistance Level
- CUE $1.99
- VOR $1.06
- Average True Range (ATR)
- CUE 0.29
- VOR 0.08
- MACD
- CUE -0.06
- VOR 0.01
- Stochastic Oscillator
- CUE 0.67
- VOR 42.32
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.